Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Leela Kodali"'
Publikováno v:
American Journal of Health-System Pharmacy. 73:441-450
Purpose The mechanism of action, pharmacodynamics, pharmacokinetics, clinical efficacy, interaction potential, adverse effects, and place in therapy of panobinostat are reviewed. Summary Panobinostat (Farydak, Novartis) is a novel pan-deacetylase inh
Vedolizumab: An integrin-receptor antagonist for treatment of Crohn’s disease and ulcerative colitis
Publikováno v:
American Journal of Health-System Pharmacy. 72:1271-1278
Purpose The pharmacology, pharmacokinetics, safety, efficacy, and dosing recommendations of vedolizumab, an integrin-receptor antagonist for the treatment of Crohn’s disease (CD) and ulcerative colitis (UC), are reviewed. Summary Vedolizumab is an
Publikováno v:
American journal of pharmaceutical education. 80(4)
Objective. To describe the design of a core course directed at improving confidence and competence of students to perform medication therapy management (MTM) services. Design. Using the American Pharmacists Association (APhA) certificate training pro
Autor:
Wahaib, Kristy1 kristy.wahaib@belmont.edu, Beggs, Ashton E.1, Campbell, Hope1, Kodali, Leela1, Ford, Patrick D.2
Publikováno v:
American Journal of Health-System Pharmacy. 4/1/2016, Vol. 73 Issue 7, p441-450. 10p. 2 Charts.
Autor:
HAHN, LINDSAY1 lindsay.hahn@belmont.edu, BEGGS, ASHTON1, WAHAIB, KRISTY1, KODALI, LEELA1, KIRKWOOD, VANESSA2
Publikováno v:
American Journal of Health-System Pharmacy. 8/1/2015, Vol. 72 Issue 15, p1271-1278. 8p. 1 Chart.
Publikováno v:
Nashville Lifestyles; Jun2018, Vol. 20 Issue 6, p114-126, 12p, 94 Color Photographs